AMANDA HOLLOWAY: Open Payments
NPI 1174247035 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,825 in 110 payments from 18 companies in 2025. Trend: 2023 $439 · 2024 $1,529 · 2025 $1,825
Food & beverage: $1,715Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $784 |
| Regeneron Healthcare Solutions, Inc. | 8 | $174 |
| Janssen Biotech, Inc. | 3 | $132 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $107 |
| Celltrion USA Inc. | 5 | $84 |
| Madrigal Pharmaceuticals | 5 | $78 |
| QOL Medical, LLC | 3 | $74 |
| Ardelyx, Inc. | 4 | $70 |
| Gilead Sciences, Inc. | 4 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
Products named: SKYRIZI, RINVOQ, TREMFYA, XIFAXAN, VEGZELMA, REZDIFFRA, Sucraid, IBSRELA.
Industry payments across OH — which companies pay providers there.
